News | Latest Breaking News Stories & Headlines | RTÉ

Weather Warning

The European Commission in talks with BioNTech-Pfizer to buy up to 300 million doses of a potential vaccine against Covid-19

EU enters final talks for BioNTech-Pfizer vaccine

Business • 09 Sep

Pfizer has taken a roughly $500m hit to sales due to a drop in visits to hospital or the doctor's office due to Covid-19

Pfizer raises forecast despite Covid-19 impact

Business • 28 Jul

Pfizer and Moderna have launched two 30,000-subject trials of Covid-19 vaccines

Moderna, Pfizer start decisive Covid-19 vaccine trials

Business • 28 Jul

Pfizer and Germany's BioNTech are among a handful of companies racing to develop a safe and effective vaccine for Covid-19

US to pay Pfizer $1.95 billion for Covid-19 vaccines

Business • 22 Jul

The drug is one of 17 being tested on humans in a frantic global race to find a vaccine

BioNTech and Pfizer's Covid-19 vaccine shows potential

Business • 01 Jul

Sanofi expects to get approval for the potential Covid-19 vaccine it is developing with GlaxoSmithKline by the first half of next year

Sanofi eyes approval of Covid-19 vaccine by H1 2021

Business • 23 Jun

Pfizer is among the many drugmakers in the race to develop a vaccine to end the Covid-19 pandemic

Pfizer sticks to forecast after Q1 profit boost

Business • 28 Apr

Mylan and Pfizer blame the coronavirus pandemic for the delay to their merger deal

Mylan, Pfizer delay merger due to Covid-19 outbreak

Business • 26 Mar

Pfizer has today raised its earnings forecast for the year

Pfizer beats profit estimates, ups earnings forecast

Business • 29 Oct 19

Purdue Pharma has agreed tentative multibillion-dollar deal with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in the US opioid crisis

Purdue deal to rank among biggest in pharma history

Business • 16 Sep 19

The new company is to be based in the United States and incorporated in Delaware

Mylan to combine with Pfizer's off-patent drugs unit

Business • 29 Jul 19

Pfizer has been investing in cancer drugs and gene therapies in the face of competition for its blockbuster pain drug Lyrica

Pfizer buys cancer drug developer Array for $10.64 bn

Business • 17 Jun 19

SITPU members at Pfizer's Ringaskiddy plant in Co Cork will strike for 24 hours on 15 February

Pfizer workers to strike in dispute over pension change

Munster • 31 Jan 19

Pfizer said its revenue rose about 2% to $13.98 billion in the fourth quarter

Pfizer forecasts 2019 revenue and profit below targets

Business • 29 Jan 19

Emma Walmsley, the chief executive of GlaxoSmithKline

GSK and Pfizer to combine consumer health businesses

Business • 19 Dec 18

Pfizer shares were down 3.4% at $41.75 in pre-market trade in the US

Pfizer cuts revenue forecast

Business • 30 Oct 18

Pfizer's proposed three new units are innovative medicines, established medicines and consumer healthcare

Pfizer set to split company into three units

Business • 11 Jul 18

Pfizer said its total quarterly revenue rose 1% to $12.91 billion

Pfizer sales miss as breast cancer drug disappoints

Business • 01 May 18

GSK CEO Emma Walmsley said today's deal will accelerate efforts to improve its performance

GSK buys Novartis stake in consumer healthcare venture

Business • 27 Mar 18

GSK was seen as the front runner to buy the assets from Pfizer

GSK pulls out of $20 billion race for Pfizer asset

Business • 23 Mar 18

Biogen set to buy Pfizer's experimental treatment for cognitive impairment

Biogen to buy Pfizer's neurology drug for almost $600m

Business • 12 Mar 18

Pfizer has reported an $11 billion gain from the new tax laws in the US

Pfizer books $11 billion tax gain

Business • 30 Jan 18

David Cullinane said the PAC had a duty to scrutinise every organisation that is funded by the taxpayer

PAC told TV licence fee system is broken

News • 09 Nov 17

Pfizer's earnings jumped in the 'innovative health' division, which commercialises newer products

Pfizer doubles Q3 profits, raises full-year forecast

Business • 31 Oct 17

Pfizer's consumer healthcare business, whose brands include Advil and Chapstick, had revenue of $3.4 billion in 2016

Pfizer weighs sale of consumer healthcare business

Business • 11 Oct 17

Showing 1 - 25 of 77 stories